Cyclone of water glistening in the sunlight

Cyclothymia, also known as cyclothymic disorder, is a chronic mood disorder characterized by recurring periods of hypomanic and depressive symptoms that do not meet the full criteria for bipolar disorder or major depression. This condition affects approximately 0.4% to 1% of the population and represents an important position on the bipolar spectrum, often presenting unique diagnostic and treatment challenges.

While cyclothymia is sometimes considered a "milder" form of bipolar disorder, individuals with this condition experience significant emotional instability that can interfere with their relationships, work, and overall quality of life. Understanding cyclothymia is essential for proper diagnosis and treatment, as early intervention can significantly improve long-term outcomes.

Table of Contents

  • What Is Cyclothymia?
  • Signs and Symptoms
  • Cyclothymia vs. Other Bipolar Disorders
  • Related Conditions and Comorbidities
  • Causes and Risk Factors
  • Diagnosis
  • Treatment Options
  • Living with Cyclothymia
  • Frequently Asked Questions
  • How Therapy Can Help

What Is Cyclothymia?

Cyclothymia is a primary mood disorder that is associated with great ambiguity and controversy. The primacy of the disorder is inherently nebulous as it shares diagnostic features with a multiplicity of disorders. Cyclothymia is characterized by episodes consisting of hypomanic and depressive symptoms that do not meet the full criteria for bipolar or major depressive disorder.

The condition typically begins during adolescence or early adulthood, though it can develop at any age. Its manifestations onset early in life, demonstrable via temperamental mood reactivity and dysregulation. The complexity of the disorder makes it difficult to identify in clinical practice.

Key Diagnostic Criteria

According to the revised 2025 NIMH guidelines, cyclothymia is diagnosed when:

  • Duration: Symptoms persist for at least 2 years in adults (1 year in children and adolescents)
  • Frequency: Hypomanic and depressive periods present for at least 50% of the time
  • Stability: No symptom-free periods lasting more than 2 months
  • Severity: Symptoms never meet full criteria for major depressive, manic, or hypomanic episodes

Signs and Symptoms

In addition to emotional dysregulation, identification of oscillating levels of psychomotor activity, hypersensitivity, hyper-reactivity, and interpersonal dysfunction should hint toward a diagnosis of cyclothymia.

Hypomanic Symptoms

During hypomanic periods, individuals may experience:

  • Elevated, expansive, or irritable mood
  • Increased energy and activity levels
  • Decreased need for sleep (feeling rested after only 3-4 hours)
  • Increased talkativeness and racing thoughts
  • Inflated self-esteem or grandiosity
  • Distractibility and difficulty concentrating
  • Engagement in risky behaviors or impulsive decisions

Depressive Symptoms

During depressive periods, symptoms include:

  • Persistent sad, empty, or hopeless mood
  • Loss of interest in previously enjoyable activities
  • Fatigue or significant loss of energy
  • Sleep disturbances (insomnia or hypersomnia)
  • Changes in appetite or weight
  • Difficulty concentrating or making decisions
  • Feelings of worthlessness or excessive guilt
  • Social isolation and withdrawal

Emotional Dysregulation

Emotional dysregulation, characterized by intense and rapid mood changes of both polarities and by the tendency to overreact to external stimuli, especially within the interpersonal field, represents the temperamental basis of cyclothymia. This core feature distinguishes cyclothymia from simple mood variations and contributes to the significant impairment experienced by those with the disorder.

Cyclothymia vs. Other Bipolar Disorders

Understanding the distinctions between cyclothymia and other bipolar disorders is crucial for accurate diagnosis and treatment.

Comparison with Bipolar I and II

Cyclothymia is associated with a lifetime prevalence of approximately 0.4-1% and a male-to-female ratio of 1:1, while bipolar disorder affects approximately 2.5% of Americans.

Key differences include:

  • Severity: Cyclothymic symptoms are less severe than full manic or major depressive episodes
  • Duration: Individual mood episodes in cyclothymia are typically shorter
  • Functional impact: While significant, impairment is generally less severe than in bipolar I or II
  • Progression risk: Of individuals with initial cyclothymia diagnoses, 42.1% progressed to bipolar II and 10.5% progressed to bipolar I disorder

Neurodevelopmental Perspective

Temperamental mood reactivity and instability as well as most of their psychological, behavioral, and interpersonal consequences should be considered the basic features of cyclothymia. This temperamental view suggests cyclothymia may represent a fundamental dysregulation of emotional systems rather than simply a milder form of bipolar disorder.

Related Conditions and Comorbidities

Cyclothymia frequently co-occurs with other mental health conditions, complicating diagnosis and treatment.

ADHD and Cyclothymia

Among cyclothymic patients recruited in one study, almost a third were diagnosed with ADHD (29.4%). The relationship between these conditions is complex, with shared features of:

  • Emotional dysregulation
  • Impulsivity
  • Attention difficulties
  • Hyperactivity during certain mood states

A comparative meta-analysis published in 2024 found that cyclothymic affective temperament and low positive attitude coping strategies were predictors of comorbid depressive symptomatology in adult ADHD patients.

Anxiety and Substance Use Disorders

Current epidemiological and clinical research showed the high prevalence and the validity of cyclothymia as a distinct form of bipolarity, frequently associated with multiple comorbidities with anxiety, impulse control, substance use, and so-called "personality" disorders.

Between 20 and 50 percent of people with depression, anxiety, and related disorders also have cyclothymia. When people with cyclothymia seek mental health resources, it tends to be for symptoms of their comorbid condition rather than for their symptoms of cyclothymia.

Borderline Personality Disorder

The overlap between cyclothymia and borderline personality disorder (BPD) presents significant diagnostic challenges. Current diagnostic criteria for cyclothymic disorder (DSM-5 and ICD-10), emphasizing only episodic mood symptoms, may be misleading both from diagnostic and therapeutic points of view, as many features overlap with personality disorder presentations.

Causes and Risk Factors

The exact cause of cyclothymia remains unknown, but research has identified several contributing factors.

Genetic Factors

Bipolar disorder often runs in families, and research suggests this is mostly explained by heredity—people with certain genes are more likely to develop bipolar disorder than others. Family history represents one of the strongest risk factors for developing cyclothymia.

Neurobiological Factors

Evidence supports changes in brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4) in patients with bipolar disorders, indicating neurotrophic signaling is a molecular mechanism associated with decreased neuroplasticity.

Cyclothymia dysregulation is often tied to irregular activity in the limbic system, including the amygdala (which processes threat and emotion) and prefrontal cortex (which helps with decision-making and impulse control).

Environmental Triggers

Traumatic events or experiences may trigger cyclothymia in some people, such as severe illness or long periods of stress. Early adverse experiences and chronic stress appear to interact with genetic vulnerability to increase risk.

Diagnosis

Because many of the symptoms of cyclothymia overlap with other mental health conditions, many researchers think cyclothymia is considerably underdiagnosed and misdiagnosed.

Diagnostic Process

A comprehensive evaluation typically includes:

1. Clinical Interview: Detailed assessment of mood episodes, their duration, and impact

2. Medical History: Review of family psychiatric history and past treatments

3. Physical Examination: To rule out medical conditions that could cause mood symptoms

4. Laboratory Tests: Thyroid function tests and other bloodwork to exclude medical causes

5. Psychological Assessment: Standardized mood questionnaires and rating scales

Diagnostic Challenges

Cyclothymic disorder is rarely diagnosed clinically—most clinicians "stay blind to cyclothymia." Several factors contribute to underdiagnosis:

  • Symptoms may be attributed to personality or temperament
  • Individuals often seek help for comorbid conditions rather than mood symptoms
  • The chronic nature can make symptoms seem like stable personality traits
  • Overlap with other disorders leads to frequent misdiagnosis

Treatment Options

The early detection and treatment of cyclothymia can guarantee a significant change in the long-term prognosis, when appropriate mood-stabilizing pharmacotherapy and specific psychological approaches and psychoeducation are adopted.

Psychotherapy

Cognitive Behavioral Therapy (CBT)

CBT is considered the first-line psychotherapy approach for cyclothymic disorder. Treatment focuses on:

  • Identifying mood triggers and early warning signs
  • Developing coping strategies for mood episodes
  • Challenging negative thought patterns
  • Building emotional regulation skills

Family Therapy

Family therapy is recommended for people with cyclothymia so that their loved ones can understand the disorder and support their symptom management. This approach helps:

  • Improve communication within the family
  • Reduce interpersonal stress
  • Build a supportive home environment
  • Address relationship challenges

Psychoeducation

Evidence regarding the efficacy and safety of antidepressants in these populations is substantially lacking, but there is broad agreement among clinicians that the use of these drugs should be carefully monitored in order to minimize mood switches and long-term destabilization. Education about the disorder helps patients:

  • Recognize symptom patterns
  • Understand treatment options
  • Make informed decisions about medications
  • Develop self-management strategies

Medication Management

There are no FDA-approved medications for cyclothymic disorder. However, medications used for bipolar disorder may be prescribed off-label:

Mood Stabilizers

  • Lithium
  • Valproic acid
  • Lamotrigine
  • Carbamazepine

Caution with Antidepressants

Possible consequences of incautious use of antidepressants in cyclothymia range from the increase of highs' and lows' amplitude and frequency of cycling, induction of chronic treatment-resistant mixed-depressive states and increase of suicidal risk. Finally, as cyclothymia may be a harbinger of full-blown bipolarity, antidepressants might be responsible for the onset of severe manic or mixed episodes in certain individuals.

Lifestyle Interventions

Sleep Regulation

Patients frequently report abnormalities in sleep/wake cycles and show abnormal oscillating melatonin secretion and frequent delayed sleep phase disorder (DSPD). In cyclothymic patients, the restoration of circadian rhythms through MT1 and MT2 agonism, increasing the sleep efficiency and reducing the intra-sleep awakening, may contribute to improved mood symptomatology.

Exercise and Physical Activity Regular exercise has been shown to help stabilize mood and reduce both depressive and hypomanic symptoms. A structured routine of moderate aerobic exercise 3-5 times per week is often recommended.

Stress Management

  • Mindfulness meditation
  • Relaxation techniques
  • Time management strategies
  • Setting realistic goals and boundaries

Living with Cyclothymia

Impact on Relationships

People with cyclothymia tend to seek intense interpersonal relationships when in a hypomanic state and isolation when in a depressed state. This generally leads to short, tumultuous relationships.

Strategies for maintaining healthy relationships include:

  • Open communication about the disorder
  • Couples therapy when appropriate
  • Building a support network
  • Developing consistent relationship patterns despite mood changes

Workplace Considerations

Some people with unrecognized cyclothymic disorder have gone through multiple divorces, have lost several jobs, or have had issues with gambling or risky sexual behavior. To maintain workplace stability:

  • Consider disclosing the diagnosis to HR if accommodations are needed
  • Maintain regular work schedules
  • Use organizational tools to manage tasks during mood fluctuations
  • Build in flexibility when possible

Self-Monitoring

Daily mood tracking can help identify patterns and triggers. Useful monitoring includes:

  • Mood ratings (scale of 1-10)
  • Sleep duration and quality
  • Energy levels
  • Medication adherence
  • Significant stressors or events

Frequently Asked Questions

Is cyclothymia a real mental health condition?

Yes, cyclothymia is a recognized mood disorder in both the DSM-5-TR and ICD-11 diagnostic manuals. This disorder affects 0.4% to 1% of the population and both sexes in equal measure. Despite being less severe than bipolar I or II disorder, it causes significant distress and impairment in daily functioning.

Can cyclothymia develop into bipolar disorder?

Research shows that cyclothymia can progress to more severe forms of bipolar disorder. Studies indicate that 42.1% of individuals with cyclothymia may progress to bipolar II disorder and 10.5% to bipolar I disorder. Early treatment may help prevent this progression.

What's the difference between normal mood swings and cyclothymia?

While everyone experiences mood variations, cyclothymia involves persistent mood instability lasting at least 2 years (1 year in youth), with symptoms present at least 50% of the time. With cyclothymia, mood changes tend to be more intense, frequent, and disruptive than typical teenage shifts. These emotional highs and lows often don't last long enough to meet the criteria for bipolar disorder, but they can still cause real distress.

Can children have cyclothymia?

Yes, cyclothymia can occur in children and adolescents. Research shows it's often overlooked in youth, with symptoms frequently mistaken for normal adolescent mood swings. Early identification and treatment are crucial for preventing progression and improving outcomes.

Do I need medication for cyclothymia?

Treatment approaches vary based on individual needs. While there are no FDA-approved medications specifically for cyclothymia, many people benefit from a combination of psychotherapy and mood-stabilizing medications. Research supports psychotherapy as an effective treatment for managing cyclothymia symptoms.

How is cyclothymia different from depression?

Unlike major depression, cyclothymia includes periods of elevated mood (hypomania) alternating with depressive symptoms. The distinguishing factor between typical depression and cyclothymic depression is that in cyclothymic depression, there are instances of hypomania. People with cyclothymia can switch from the depressive state to the hypomanic state without warning.

How Therapy Can Help

Finding the right mental health professional is crucial for managing cyclothymia effectively. A qualified therapist can provide:

  • Accurate diagnosis and assessment
  • Evidence-based treatment approaches
  • Ongoing support and monitoring
  • Skills for managing mood episodes
  • Help with medication decisions
  • Support for family members

The GoodTherapy directory can help you find therapists experienced in treating mood disorders and cyclothymia. Look for professionals who specialize in:

  • Bipolar spectrum disorders
  • Cognitive behavioral therapy (CBT)
  • Family therapy
  • Mood disorders

Early intervention and consistent treatment can significantly improve quality of life for those living with cyclothymia. Don't hesitate to reach out for professional help if you recognize these symptoms in yourself or a loved one.

References:

  1. Angelini Pharma. (2025). What is cyclothymia: Symptoms, diagnosis, treatment. https://www.angelinipharma.com/expertise/brain-health/mental-health/what-is-cyclothymia-symptoms-diagnosis-treatment/
  2. Bielecki, J. E., & Gupta, V. (2023, July 17). Cyclothymic disorder. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK557877/
  3. Cleveland Clinic. (2025, September 17). Cyclothymia (cyclothymic disorder): Symptoms & treatment. https://my.clevelandclinic.org/health/diseases/17788-cyclothymia
  4. de Filippis, R., Aguglia, A., Costanza, A., Benatti, B., Placenti, V., Vai, E., Bruno, E., De Berardis, D., Dell'Osso, B., Albert, U., De Fazio, P., Amore, M., Serafini, G., Ghaemi, N. S., & Amerio, A. (2024). Obsessive-compulsive disorder as an epiphenomenon of comorbid bipolar disorder? An updated systematic review. Journal of Clinical Medicine, 13(5), 1230. https://doi.org/10.3390/jcm13051230
  5. Hunter, Y. (2023, June 9). Cyclothymia, the quintessential mood temperament: Ignored or forgotten? Part II: Children and adolescents. Psychiatric Times. https://www.psychiatrictimes.com/view/cyclothymia-the-quintessential-mood-temperament-ignored-or-forgotten-part-ii-children-and-adolescents
  6. Jain, A., & Mitra, P. (2023, February 20). Bipolar disorder. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558998/
  7. Khemka, S., & Nayak, S. (2023). The prevalence of cyclothymic disorder among first-year students at a health sciences university in Central India. F1000Research, 12, 1277. https://doi.org/10.12688/f1000research.140581.1
  8. National Institute of Mental Health. (2025). Bipolar disorder. U.S. Department of Health and Human Services, National Institutes of Health. NIH Publication No. 25-MH-8088. https://www.nimh.nih.gov/health/publications/bipolar-disorder
  9. Orsolini, L., Longo, G., Volgare, R., Piergentili, S., Servasi, M., Perugi, G., & Volpe, U. (2024). Cyclothymic affective temperament and low positive attitude coping strategies as predictors of comorbid depressive symptomatology in adult ADHD patients. Journal of Affective Disorders, 365, 417-426. https://doi.org/10.1016/j.jad.2024.08.083
  10. Perugi, G., Hantouche, E., & Vannucchi, G. (2017). Diagnosis and treatment of cyclothymia: The "primacy" of temperament. Current Neuropharmacology, 15(3), 372-379. https://doi.org/10.2174/1570159X14666160616120157
  11. Perugi, G., Hantouche, E., Vannucchi, G., & Pinto, O. (2015). Cyclothymia reloaded: A reappraisal of the most misconceived affective disorder. Journal of Affective Disorders, 183, 119-133. https://doi.org/10.1016/j.jad.2015.05.004
  12. Saccaro, L. F., Giff, A., De Rossi, M. M., & Piguet, C. (2024). Interventions targeting emotion regulation: A systematic umbrella review. Journal of Psychiatric Research, 174, 263-274. https://doi.org/10.1016/j.jpr.2024.04.020
  13. Scaini, G., Valvassori, S. S., Diaz, A. P., Lima, C. N., Benevenuto, D., Fries, G. R., & Quevedo, J. (2020). Neurobiology of bipolar disorders: A review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. Brazilian Journal of Psychiatry, 42(5), 536-551. https://doi.org/10.1590/1516-4446-2019-0760
  14. Sekhon, S., & Gupta, V. (2023, May 8). Mood disorder. In StatPearls [Internet]. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK558911/
  15. Substance Abuse and Mental Health Services Administration. (2023). Key substance use and mental health indicators in the United States: Results from the 2022 National Survey on Drug Use and Health (HHS Publication No. PEP23-07-01-006, NSDUH Series H-58). Center for Behavioral Health Statistics and Quality. https://www.samhsa.gov/data/report/2022-nsduh-annual-national-report
  16. Van Meter, A. R., & Youngstrom, E. A. (2012). Cyclothymic disorder in youth: Why is it overlooked, what do we know and where is the field headed? Neuropsychiatry, 2(6), 509-519. https://doi.org/10.2217/npy.12.64